Education
About Us
Working with TipRanks
Follow Us
SS Innovations International (SSII)
NASDAQ:SSII
SSII Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.32 - $22.42
Previous CloseN/A
Volume157.00
Average Volume (3M)373.71K
Market Cap
$966.08M
Enterprise Value$914.20M
Total Cash (Recent Filing)$15.87M
Total Debt (Recent Filing)$10.45M
Price to Earnings (P/E)―
Beta8.83
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding193,603,970
10 Day Avg. Volume112,496
30 Day Avg. Volume373,710
Financial Highlights & Ratios
PEG Ratio2.11
Price to Book (P/B)20.95
Price to Sales (P/S)0.00
P/FCF Ratio-53.59
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue13.28
Enterprise Value/Gross Profit148.40
Enterprise Value/Ebitda-10.81
Forecast
1Y Price Target
$7.00Price Target Upside40.28% Upside
Rating ConsensusHold
Number of Analyst Covering0
SS Innovations International News
PremiumCompany Announcements
SS Innovations Expands Global Reach with Robotic Systems
PremiumCompany Announcements
SS Innovations Completes First Robotic Telesurgery
PremiumCompany Announcements
SS Innovations Completes First Robotic Cardiac Surgery
PremiumCompany Announcements
SS Innovations Unveils New Strategic Expansion Plans
PremiumCompany Announcements
SS Innovations Rings Nasdaq Bell After UplistingPremiumCompany Announcements
SS Innovations Hits 4,000 Surgeries MilestonePremiumCompany Announcements
SS Innovations Appoints New CEO for Asia PacificPremiumCompany Announcements
SS Innovations Reports Record Q1 Revenue GrowthOptions Prices
Currently, No data available
---
Ownership Overview
71.20% Insiders
―
Mutual Funds
― Other Institutional Investors
28.80% Public Companies and
Individual Investors
SSII FAQ
What was SS Innovations International’s price range in the past 12 months?
SS Innovations International lowest stock price was $0.32 and its highest was $22.42 in the past 12 months.
What is SS Innovations International’s market cap?
SS Innovations International’s market cap is $966.08M.
When is SS Innovations International’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SS Innovations International’s earnings last quarter?
Currently, no data Available
Is SS Innovations International overvalued?
According to Wall Street analysts SS Innovations International’s price is currently Undervalued.
Does SS Innovations International pay dividends?
SS Innovations International does not currently pay dividends.
What is SS Innovations International’s EPS estimate?
SS Innovations International’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SS Innovations International have?
SS Innovations International has 193,603,970 shares outstanding.
What happened to SS Innovations International’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SS Innovations International?
Currently, no hedge funds are holding shares in SSII
SS Innovations International Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$7.00 (40.28% Upside)
$7.00 (40.28% Upside)
Blogger Sentiment
Bullish
SSII Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $5.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.06%
12-Months-Change
Fundamentals
Return on Equity
-52.32%
Trailing 12-Months
Asset Growth
80.27%
Trailing 12-Months
Company Description
SS Innovations International
SS Innovations International (SSII) is a pioneering company in the field of medical technology, primarily focusing on the development and manufacturing of advanced surgical robotic systems. The company operates within the healthcare sector, offering innovative solutions designed to enhance surgical precision and patient outcomes. SSII aims to transform the medical landscape by providing state-of-the-art products that support minimally invasive surgeries across various medical disciplines.
Technical Analysis
Travere Therapeutics
―
Arcutis Biotherapeutics
―
Disc Medicine
―
Kymera Therapeutics
―
GoodRx Holdings
―